Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that it has been ...

Gastric cancer is one of the main causes of cancer death in China. Most of these patients have poor prognosis because of late presentation and diagnosis. The best tactics for dealing with gastric ...

Under the liquidity contract between the company MAUNA KEA TECHNOLOGIES (Paris:ALMKT) and the brokerage firm Gilbert Dupont, the following resources appeared on the liquidity account ...